We have an exciting opportunity for a Postdoctoral Researcher to join Professor Eric O’Neill’s group as part of an enthusiastic research team focusing on signalling events that occur during cell transformation, in particular the initiating events in human cancer. This Cancer Research UK funded post will expand on our recent research into the role of key pathway components in the hippo pathway and investigate links between the nuclear envelope, maintenance of genomic integrity and centrosome/primary cilia biology. We aim to investigate the function of the ATR-RASSF1A signalling nexus in normal cells, e.g. stem cells, organoids, and how this is perturbed in emerging pathologies. This project will also aim to confirm these findings in model systems and clinical trial material.
You will have (or be working towards) a PhD in biological sciences with knowledge of cancer biology and cancer research. Experience with cell signalling and start of the art imaging software is essential, together with evidence of prior publications as a first author in peer-reviewed scientific journals. An understanding of pancreatic or brain cancers would be advantageous.
This is a full-time post offered for a fixed-term of 3 years.
All applicants must complete an application form and upload a CV and supporting statement.
The closing date for applications is 12.00 noon on 18 August 2017.